Engineers Gate Manager LP Chroma Dex Corp. Transaction History

Engineers Gate Manager LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.44 - $4.32 $26,901 - $47,628	11,025 New	11,025 $30,000
Q2 2022 Aug 15, 2022	BUY	$1.59 - $2.7 $37,859 - $64,289	23,811 New	23,811 $40,000
Q4 2021 Feb 14, 2022	SELL	$3.74 - $6.7 $64,036 - $114,717	-17,122 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.05 - $10.41 $93,539 - $160,949	-15,461 Reduced 47.45%	17,122 $107,000
Q2 2021 Aug 16, 2021	SELL	$6.66 - $10.92 $226,213 - $370,908	-33,966 Reduced 51.04%	32,583 $321,000
Q1 2021 May 17, 2021	BUY	$4.59 - $18.74 $305,459 - $1.25 Million	66,549 New	66,549 $622,000
Q4 2019 Feb 14, 2020	SELL	$2.83 - $4.61 $77,663 - $126,512	-27,443 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$3.83 - $4.72 $105,106 - $129,530	27,443 New	27,443 $108,000

17.2M

66.7K

8.2K

Ticker CDXC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,350,896
Market Cap $509M
Description
ChromaDex Corporation operates as a bioscience company focusing on healthy aging. The company operates through three segments: Consumer products; Ingredients; and Analytical Reference Standards and Services. It researches on nicotinamide adenine dinucleotide (NAD+); provides finished dietary supplement products that contain its proprietary ingre...

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

Stay updated on Engineers Gate Manager LP with notifications on news.